Galderma Labs Seeks OK Of Award Over Botox-Like Treatment

By Joyce Hanson · January 3, 2024, 10:10 PM EST

Galderma Laboratories has asked a Texas federal court to enforce an arbitral award in its trade secrets dispute with Ipsen Biopharm over an application seeking U.S. government approval of a Botox-like...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Ipsen Biopharm Ltd et al v. Galderma Laboratories LP et al

Case Number

3:23-cv-02593

Court

Texas Northern

Nature of Suit

Other Statutes: Arbitration

Date Filed

November 22, 2023